After more than a year of community engagement and preparation in 100 villages with 12,000 populations across the Chittagong Hill Tracts, the mass malaria vaccine (R21/Matrix M) and drug (DHA, piperaquine, and single low dose primaquine) administration study started on 15 Feb.
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
A team of researchers at OUCRU was recently awarded a multi-million-dollar Discovery Award from the Wellcome Trust to develop AI tools to advance pneumonia research.
Twenty eight young people from the UK and Japan played a leading role in co-designing the research, interviewing other young people and adults, analysing the findings, and developing the recommendations for policy makers.
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics \u2013 as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
The International Day of Women and Girls in Science, observed on February 11, serves as a reminder of the gender disparities that persist in the Science, Technology, Engineering and Mathematics (STEM) fields.
International, national and local partners have been welcomed to the launch of the world\u2019s first centre dedicated to empowering global epilepsy research and care.
Researchers in the Nuffield Department of Medicine and their collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial. The new method analyses the vaccine vial label and its adhesive and therefore allows genuine vaccine vials to be retained in the supply chain. This technique can also differentiate genuine Covid-19 vaccine liquid from falsified vaccine surrogates.
Professor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology at NDM\u2019s Centre for Tropical Medicine and Global Health and the Big Data Institute, looks at potential ways to advance research on the impact of climate change on malaria and neglected tropical diseases (NTDs).
The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has found that sotrovimab reduced the risk of death in patients hospitalised with COVID-19, but only in those with higher levels of the virus present in their blood. The results have been published on medRxiv and will be submitted to a peer-reviewed medical journal.
The Global Health Network has achieved a remarkable milestone: one million members worldwide. This dynamic and inclusive community of healthcare professionals and researchers is addressing two of the most pressing challenges in global health. By equipping teams to tackle everyday diseases of poverty and strengthening the ability to detect and respond to emerging threats, The Global Health Network is saving lives and safeguarding the future of global health.
In Myanmar, the United Nations reports that 3 million people have been displaced due to the ongoing civil war. The 2021 coup intensified conflicts and worsened the humanitarian crisis, forcing at least a hundred thousand to seek refuge and medical care in Thailand.
An important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.
OUCRU Ha Noi and the National Hospital for Tropical Diseases (NHTD), under the guidance of the Department of Health, are collaborating to establish local hospital networks for Antimicrobial Stewardship (AMS) across Vietnam. This initiative, connecting district hospitals with provincial hospitals, leverages existing systems and resources to enhance AMS implementation and strengthen efforts against antimicrobial resistance (AMR).
National microbiology reference laboratories are central to global health and must be adequately funded, according to a viewpoint article published in The Lancet Digital Health by researchers at Oxford Population Health and the Invasive Respiratory Infection Surveillance (IRIS) Consortium.
Nigerian poet, Chiwenite Onyekwelu, is the winner of the first poetry competition to consider concepts of endings, with his poems \u2018On Memory and Forgetting\u2019 and \u2018Time/Our Time\u2019. \u2018On Memory and Forgetting\u2019 describes Onyekwelu\u2019s father\u2019s recollections of the Biafra war and \u2018Time/ Our Time\u2019 reflects on the impact of oil spills into the Niger Delta.
An international study involving researchers at the Leverhulme Centre for Demographic Science has found significant effects of the COVID-19 pandemic on many causes of death across 24 countries.
Mahidol Oxford Tropical Medicine Research Unit (MORU) have led the world\u2019s largest study on the use of hydroxychloroquine and chloroquine to prevent COVID-19. With results showing moderate protection against the virus, the trial involved over 4,600 participants and found a 15% reduction in symptomatic COVID-19 among those who took the medications compared to those who took a placebo.
![\"Health](\"https://www.globalhealth.ox.ac.uk/news/bangladesh-malaria-mass-vaccine-and-drug-administration-trial-begins/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n